What You Should Know:
4medica®, a healthcare data quality and matching technology company, today announced that the 4medica Enterprise Master Patient Index (EMPI) platform is now available on Google Cloud Marketplace.Built on Google Cloud’s Healthcare API, 4medica’s EMPI offers healthcare organizations access to a highly scalable data management services such as referential matching and identity enrichment.
Impact of Poor Healthcare Data Quality
Far
Read More
AristaMD Launches Unified Care Transition Platform
What You Should Know:
- AristaMD, a digital healthcare company specializing in eConsult and referral management services, today announced the launch of a unified care transition platform.
- The platform seamlessly integrates patient-to-provider matching, electronic referral processing, and eConsults into one single interoperable solution for primary care providers (PCPs). The end-to-end referral solution ensures that all patients receive timely care from the right provider in the right
Read More
FDA & Cerner Enviza Collaborate to Develop AI Tools for Drug Safety
What You Should Know:
- Cerner Enviza, an Oracle company, and FDA’s Sentinel Innovation Center are teaming up to develop AI tools to extract and assess clinical notes to better understand drug safety.
- Teaming with John Snow Labs, Cerner Enviza will use AI and NLP to develop tools to extract information from clinical notes within the EHR to better aid in better understanding the effects of medicines on large populations. The project known as the Multi-source Observational
Read More
Drug Discovery Outsourcing Market Expected to Reach $7.5B by 2033
What You Should Know:
The drug discovery outsourcing market is expected to reach $3.75B in 2023 and is expected to grow at a steady CAGR of 7.2% and is expected to reach $7.52B by 2033, according to a new report by Future Market Insights.The research report on the drug discovery outsourcing market states that the pharmaceutical industry is expanding thoroughly with new extensions and high-end research programs.
AI Drug Discovery Outsourcing for Cost-Savings
The
Read More
PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
What You Should Know:
- PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.
The platform supports phenotypic drug discovery, which unlike traditional target-based drug discovery, can identify novel treatments with multiple targets.
How eCube Works
eCube measures drug-induced changes to EEG spectra data and utilizes machine learning classifiers trained
Read More
Intermountain Health Expands Relationship with Kyruus for Rebranded Digital Patient Experience
What You Should Know:
- Intermountain Health announced it is expanding the use of Kyruus’ ProviderMatch® platform to power a new digital patient experience initiative.
- This expansion builds on an existing relationship with Kyruus via legacy SCL Health (now Intermountain) in which Kyruus overhauled the system’s provider directory and replaced its existing online scheduling solution, which in less than a year, yielded a 21% increase in appointments scheduled online.
- As
Read More
HouseWorks Acquires Amedisys’ Personal Care Division
What You Should Know:
- HouseWorks LLC, a provider of personal care services in Massachusetts, New Hampshire, Pennsylvania, and Maine has acquired Associated Home Care, the Personal Care division at Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and high-acuity care.
- HouseWorks, in partnership with eCaring, joins the Amedisys personal care network and forms a care coordination partnership to deliver comprehensive, seamless care to the communities both
Read More
MEDITECH Taps IHM as Data Ally to Advance Health Equity
What You Should Know:
- MEDITECH today announced they have recognized the Institute for Health Metrics (IHM) as their data collaborator to support and accelerate health equity at hospitals across the country.
- Member hospitals will benefit from cleansed clinical data and data enhancement, including Social Determinants of Health (SDOH) data, and receive curated information and insight, as well as grant funding for health equity initiatives.
Read More
Interoperability Platform Lyniate Rebrands as Rhapsody
What You Should Know:
- Global interoperability leader Lyniate has rebranded as Rhapsody in order to leverage the brand’s prestigious global recognition. Originally founded as Rhapsody in 2018, the company will continue to provide top-of-the-line interoperability solutions while maintaining its commitment to addressing data-sharing challenges and improving outcomes.
- Going forward, the company will use the Rhapsody brand for its suite of interoperability solutions and will
Read More
Dionysus Accelerates Advancement in Maternal Health with Artificial Intelligence
What You Should Know:
Today, the National Institutes of Health (NIH) announced that Dionysus Digital Health, Inc. (Dionysus), a digital health company engaged in the development of precise medical insights using a proprietary digital and epigenetic analysis platform, was selected to move to the next phase of the Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge. The $8 million cash prize challenge will accelerate the development of technologies to
Read More
